In this episode of KingsCrowd's "Investment Roundtable," our experts, Brian Belley, Teddy Lyons, and Léa Bouhelier-Gautreau, explore the booming HealthTech and pharmaceutical sectors in regulation crowdfunding. They dive into top investment opportunities, including Future Cardia's innovative heart monitor and Ajna Biosciences' plant-based pharmaceuticals for autism and anxiety. Learn about the FDA approval process, key risks, and why these startups are attracting major investor interest. Tune in to get the inside scoop on the latest trends and opportunities in this high-stakes industry! Key Takeaways: HealthTech & Pharma Boom: The healthcare and pharmaceutical sectors have seen significant traction in regulation crowdfunding, with numerous offerings and high capital raised. Future Cardia Spotlight: Future Cardia's heart monitor, designed for continuous patient monitoring, is progressing towards FDA approval through the 510(k) pathway, which could fast-track its market entry. Ajna Biosciences Overview: Ajna Biosciences is developing plant-based pharmaceuticals for autism and anxiety, targeting conditions with significant unmet needs and lessening side effects compared to traditional drugs. FDA Approval Insights: The episode breaks down the different FDA approval pathways, highlighting the complexities and potential risks involved in bringing new medical devices and drugs to market. Investment Risks & Rewards: The discussion includes potential risks such as the capital-intensive nature of these startups and the regulatory hurdles they must overcome, balanced against the high potential rewards in these innovative sectors.